Nordisk and Eli Lilly are set to reshape the oral GLP-1 market as patient demand grows and new therapies emerge. Learn more ...

Eli Lilly (LLY) saw notable developments in September, with the launch of Lilly TuneLab, an AI/ML platform designed to ...

Eli Lilly dominates obesity and diabetes treatments with soaring tirzepatide sales and promising oral drug data. Find out why ...

A federal appeals court on Thursday rejected Eli Lilly's appeal of an $183.7 million judgment won by a whistleblowing lawyer ...

Novo Nordisk, the maker of weight loss drug Wegovy, will lay off about 9,000 people as it grapples with rising competition in ...

Eli Lilly plans to build a massive $5.9 billion campus that could change the landscape of Northeast Houston’s Generation Park ...

In recent years, Lilly's top line has been growing at a much faster pace thanks to its already approved GLP-1 injections, ...

Eli Lilly and Company (NYSE: LLY) is one of the stocks to invest in before they split next. On September 9, Eli Lilly and Company launched a new global campaign titled “Brain Health Matters” to ...

Apple (NASDAQ: AAPL) and Eli Lilly (NYSE: LLY) share several similarities. Both are long-standing leaders in their respective ...

Eli Lilly (NYSE: LLY) stock has soared in the triple digits over the past three years thanks to one particular product line: ...

We recently compiled a list of the 10 High Growth Pharma Stocks That Are Profitable in 2025. Eli Lilly and Company is one of them. Eli Lilly and Company (NYSE:LLY) tops our list for being one of the ...

Lila Biologics, a spinoff from Nobel Laureate David Baker’s research at the University of Washington, is collaborating with ...